The purpose of this study is to learn how microbes in the uterus and gut (bacteria, viruses, fungi) and your own innate immune system (the first line of defense of the body) impacts how well certain treatments work for endometrial cancer. This is a hybrid decentralized study where some if not all assessments may be performed close to your home.

Do you have protein in your urine and have had a kidney biopsy? You may be able to participate in a research study to test to see if a study drug can reduce the amount of protein in your urine.

Do you or your child have hidradenitis suppurativa? Would you be interested in hearing more about a clinical study on hidradenitis suppurativa? If so, you may be able to participate in a research study to find out how effective and safe the study medication Ruxolitinib is in patients with hidradenitis suppurativa.

This research study aims to investigate the use of circulating tumor DNA (ctDNA) monitoring to detect early signs of cancer recurrence in patients with triple-negative breast cancer (TNBC) after standard treatment. TNBC is aggressive and has a higher risk of recurrence, often detected only after symptoms appear. This study will monitor ctDNA levels through blood samples collected during and after adjuvant therapy. If ctDNA is not detected, participants will continue monitoring. If ctDNA is detected, the study offers an investigational treatment, datopotamab deruxtecan (Dato-DXd), to address this potential recurrence risk. Participation in this study will help determine if ctDNA monitoring can improve the early detection of recurrence and potentially lead to better treatment strategies and outcomes for patients with TNBC in the future.

Do you have cancer that has spread to your bones (high-risk bone metastases)? Is your cancer not causing any pain, or asymptomatic? If so, you may be able to take part in a research study comparing the standard approach with the standard approach plus radiation therapy to see if it's better at lowering bone metastases-related complications.

By joining, you'll share important health information in a secure research registry to help scientists: -Understand how the immune system reacts to food -Improve diagnosis and treatment -Develop prevention strategies and new therapies

In this study, we're interested in understanding couples' experiences with using ChatGPT and each other for emotional support. We are recruiting couples to take part in a paid virtual study! This study includes 21 days of short online surveys sent via email, and you can earn up to $34 each for your participation.

Researchers are trying to find out if they can slow the growth of prostate cancer by adding green tea to patients treatment. Researchers are also trying to find out if this could be better or worse than usual care patients get.

Do you have advanced Stage III or IV Head and Neck Cancer? You might be able to join a research study. We are looking at new treatments compared to the usual care for your type of cancer.

We are doing a study to see if a new treatment, called INO-3107, can help people with recurrent respiratory papillomatosis (RRP). We want to find out if this treatment works well and if it helps patients need fewer surgeries in the future.